Currently, the promotion of stem cells migration to tumor is mainly achieved through the CXCR4/ SDF-1α axis, and the expression of CXCR4 in stem cells can be further enhanced by hypoxia induction [48,49]. The gene discussed is CXCL12; the disease is neoplasm.